Topic List : Immunology
Cancer therapy may work in unexpected way
An antibody to the cell receptor PD-1 may launch a two-pronged assault on cancer by initiating attacks by both T cells and macrophages, a Stanford study has found.
Participants sought for peanut allergy studies
Scientists at Stanford are studying a vaccine and an antibody drug that may help reduce the severity of peanut allergies.
Trial led by Mark Genovese wins award
In the trial, a new drug proved safe and effective for hard-to-treat rheumatoid arthritis patients. A national organization of senior researchers named the trial one of the top 10 for 2016.
Schneider to chair microbiology and immunology
David Schneider, whose research focuses on resilience to infection and developing mathematical models to predict recovery and well-being, succeeds Peter Sarnow in post.
Drug combo effective against dengue, Ebola
To develop a potential antiviral treatment, Stanford researchers adopted an unusual approach: Rather than trying to disable viral enzymes, they targeted proteins the infected individual makes — and the virus needs.
Tumor rejection requires coordinated immune response
Effective anti-tumor activity requires a systemic, rather than only a local, immune response at the tumor site. A Stanford study may help clinicians pinpoint why only some cancer patients respond to immunotherapies.
Toxic brain cells may drive neurologic disease
Astrocytes, star-shaped cells in the central nervous system, are essential to the survival and healthy function of brain neurons. But aberrant astrocytes may be driving neurodegenerative disorders.
Inflammatory link to heart disease, death
A chronic inflammatory process that occurs in some, but not all, older people may trigger cardiovascular problems, a new Stanford study shows. Part of the solution might be found in a cup of coffee.
Gene activity foretells autoimmune disease
Stanford researchers and their collaborators have found a way to tell whether patients with systemic sclerosis were improving during drug treatment a year before a standard clinical test could.
New blood test may predict cardiovascular disease
An assessment blending several measures of immune-cell responsiveness predicted cardiovascular problems in individuals who likely would have slipped under the radar.